Denmark Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size & Outlook
Global Market
Related Markets
Denmark veterinary active pharmaceutical ingredients manufacturing market highlights
- The Denmark veterinary active pharmaceutical ingredients manufacturing market generated a revenue of USD 106.1 million in 2024 and is expected to reach USD 208.3 million by 2033.
- The Denmark market is expected to grow at a CAGR of 7.8% from 2025 to 2033.
- In terms of segment, in house was the largest revenue generating service type in 2024.
- Contract Outsourcing is the most lucrative service type segment registering the fastest growth during the forecast period.
Veterinary active pharmaceutical ingredients manufacturing market data book summary
| Market revenue in 2024 | USD 106.1 million |
| Market revenue in 2033 | USD 208.3 million |
| Growth rate | 7.8% (CAGR from 2025 to 2033) |
| Largest segment | In house |
| Fastest growing segment | Contract Outsourcing |
| Historical data | 2021 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | In House, Contract Outsourcing |
| Key market players worldwide | Zoetis Inc Class A, SeQuent Scientific, Ofichem Group, The Chem-Pro Group, Siflon Drugs & Pharmaceuticals, Vetpharma, Suanfarma Biotech, Menadiona, Excel Industries |
Other key industry trends
- In terms of revenue, Denmark accounted for 1.1% of the global veterinary active pharmaceutical ingredients manufacturing market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Europe, UK veterinary active pharmaceutical ingredients manufacturing market is projected to lead the regional market in terms of revenue in 2033.
- France is the fastest growing regional market in Europe and is projected to reach USD 666.2 million by 2033.
The veterinary API manufacturing market in Denmark is expected to grow over the forecast period. Growth in the market can be attributed to the increasing adoption of animal husbandry practices. The favorable government initiatives supporting the livestock sector are also expected to fuel market growth.
Moreover, animal health programs that involve animal health regulation supervision and pharmaceuticals & vaccine quality control measures are influencing the demand in the market positively.
The Danish Medicines Agency (DMA) authorizes, regulates, and supervises veterinary medicinal products to ensure the safety & efficacy of veterinary medicinal products. In addition, the country’s regulatory framework for animal health is designed to prevent & control infectious diseases in animals, which is expected to support the veterinary API manufacturing market growth.
No credit card required*
Publish Date: Nov 25, 2025
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Three ways to get this data
Subscribe to the databook, customize it, or ask a question.Horizon Databook
Unlock every chart on this page and get dashboard access
- Statistics1.2M+ across all markets
- Databooks30K+ global, 120K+ country
- Companies200K+ profiles
- ExportPDF, Dashboard, XLS & PNG, licensed to cite
Customize it
Customize data as per your requirement
- AddCountries, segments, years
- RecutTo your product definition
- ExtendCompany-level detail
- OrA bespoke databook
- Turnaround5–10 working days
Ask Prism AI
A cited answer in seconds
- Corpus30,000 studies, 1.2M points
- ScopeAll markets, not just this
- CitationTraced to report & table
- HonestySays "not covered" if so
- SpeedSeconds, not days
Veterinary Active Pharmaceutical Ingredients Manufacturing Market Scope
Veterinary Active Pharmaceutical Ingredients Manufacturing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Zoetis Inc Class A | View profile | 14,100 | 10 Sylvan Way, Parsippany, NJ, United States, 07054 | www.zoetis.com |
| Menadiona | View profile | 51-100 | Barcelona, Catalonia, Spain, Europe | www.menadiona.com/ |
| SeQuent Scientific | View profile | 1001-5000 | Bangalore, Karnataka, India, Asia | sequent.in |
| Ofichem Group | View profile | 51-100 | Ter Apel, Groningen, The Netherlands, Europe | ofichem.com |
| The Chem-Pro Group | View profile | 501-1000 | Mumbai, Maharashtra, India, Asia | www.chemprogroup.com |
| Siflon Drugs & Pharmaceuticals | View profile | 11-50 | Hyderabad, Andhra Pradesh, India, Asia | siflonpharma.com |
| Vetpharma | View profile | 11-50 | Barcelona, Catalonia, Spain, Europe | vetpharma.com |
| Suanfarma Biotech | View profile | 251-500 | Alcobendas, Madrid, Spain, Europe | www.suanfarma.com |
| Excel Industries | View profile | 501-1000 | Mumbai, Maharashtra, India, Asia | www.excelind.co.in |
Denmark Veterinary Active Pharmaceutical Ingredients Manufacturing Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Veterinary Active Pharmaceutical Ingredients Manufacturing Market Outlook will help companies and investors design strategic landscapes.
In House was the largest segment with a revenue share of 64.47% in 2024.
Horizon Databook has segmented the Denmark veterinary active pharmaceutical ingredients manufacturing market based on in house, contract outsourcing covering the revenue growth of each sub-segment from 2021 to 2033.
The veterinary API manufacturing market in Denmark is expected to grow over the forecast period. Growth in the market can be attributed to the increasing adoption of animal husbandry practices. The favorable government initiatives supporting the livestock sector are also expected to fuel market growth.
Moreover, animal health programs that involve animal health regulation supervision and pharmaceuticals & vaccine quality control measures are influencing the demand in the market positively.
The Danish Medicines Agency (DMA) authorizes, regulates, and supervises veterinary medicinal products to ensure the safety & efficacy of veterinary medicinal products. In addition, the country’s regulatory framework for animal health is designed to prevent & control infectious diseases in animals, which is expected to support the veterinary API manufacturing market growth.
- Denmark Veterinary Active Pharmaceutical Ingredients Manufacturing Market Service Type Outlook (Revenue, USD Million , 2021-2033)
- In House
- Contract Outsourcing
- Denmark Veterinary Active Pharmaceutical Ingredients Manufacturing Market Synthesis Type Outlook (Revenue, USD Million , 2021-2033)
- Chemical Based API
- Biological API
- HPAPI
- Denmark Veterinary Active Pharmaceutical Ingredients Manufacturing Market Therapeutic Category Outlook (Revenue, USD Million , 2021-2033)
- Antiparasitics
- Anti-infectives
- NSAIDs
- Others
- Denmark Veterinary Active Pharmaceutical Ingredients Manufacturing Market Animal Type Outlook (Revenue, USD Million , 2021-2033)
- Companion Animals
- Production Animals
Reasons to subscribe to Veterinary Active Pharmaceutical Ingredients Manufacturing Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Veterinary Active Pharmaceutical Ingredients Manufacturing Market Outlook databook
- Our clientele includes a mix of Veterinary Active Pharmaceutical Ingredients Manufacturing Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Denmark Veterinary Active Pharmaceutical Ingredients Manufacturing Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Denmark Veterinary Active Pharmaceutical Ingredients Manufacturing Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Denmark Veterinary Active Pharmaceutical Ingredients Manufacturing Market, 2021-2033 (US$M)
Denmark Service Type - Veterinary Active Pharmaceutical Ingredients Manufacturing Market Statistics, 2024 - 2033 (US$M)
